LUCD logo

LUCD
Lucid Diagnostics Inc

1,882
Mkt Cap
$182.57M
Volume
761,551.00
52W High
$1.70
52W Low
$0.9495
PE Ratio
-1.25
LUCD Fundamentals
Price
$1.03
Prev Close
$1.05
Open
$1.06
50D MA
$1.23
Beta
0.72
Avg. Volume
857,068.84
EPS (Annual)
-$0.6922
P/B
-3.12
Rev/Employee
$57,390.24
$156.51
Loading...
Loading...
News
all
press releases
Lucid Diagnostics Inc. (LUCD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Lucid Diagnostics (LUCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2d ago
News Placeholder
More News
News Placeholder
10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of +65.52% and +3.57%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates
LivaNova (LIVN) delivered earnings and revenue surprises of +15.29% and +3.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago
News Placeholder
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 PR Newswire...
PR Newswire·9d ago
News Placeholder
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on...
PR Newswire·10d ago
News Placeholder
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock PR Newswire NEW YORK...
PR Newswire·16d ago
News Placeholder
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock PR Newswire NEW YORK, April 23, 2026 NEW...
PR Newswire·17d ago
News Placeholder
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Lucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) have received an average recommendation of "Moderate Buy" from the five research firms that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation and four have assigned a b...
MarketBeat·23d ago
News Placeholder
Lucid Diagnostics (NASDAQ:LUCD) Price Target Raised to $9.00
Ascendiant Capital Markets boosted their price objective on shares of Lucid Diagnostics from $8.25 to $9.00 and gave the stock a "buy" rating in a research note on Thursday...
MarketBeat·1mo ago
News Placeholder
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual...
PR Newswire·1mo ago
<
1
2
...
>

Latest LUCD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.